Dental sleep medicine encompasses different methods of treatment for treating sleep disorders that affect the breathing pattern of the patient. Rising burden of these diseases is likely to fuel demand for these medicines in the years to come. The assessment offered by Market Research Future (MRFR) highlights that the global Dental Sleep Medicine Market
Industry is poised to record a healthy CAGR across the projection period 2016 to 2022.
The market resonates strong potential for growth in terms of unmet needs. The rising demand, triggered by increasing awareness about the sleep apnea, is likely to influence the proliferation of the dental sleep medicine market in the region over the next couple of years. However, the lack of product standardization remains an impediment to market growth.
- Koninklijke Philips N.V.
- Fisher & Paykel Healthcare
- Drive DeVilbiss Healthcare
- Apex Medical Corporation
- Curative Medical Inc
- BMC Medical Co
- The segments of the global dental sleep medicine market, on the basis of treatment, are positive airway pressure (PAP) therapy, airway systems, oral and nasal devices, drugs, surgery, and other devices.
- Based on diagnostics, the dental sleep medicine market has been segmented into home oximetry, actigraph, polysomnography, and respiratory polygraphy.
- The key end-users of the global dental sleep medicine market profiled in this report are sleep laboratories, hospitals, and home.
The geographical assessment of the global dental sleep medicine market spans across four major regions, namely North America, the Middle East & Africa (MEA), Europe, and Asia Pacific. North America led the growth pattern of the global dental sleep medicine market in 2016 and is likely to retain its leading position over the next couple of years. Most of the major key players are based out of the region, and their growth strategies are expected to propel the proliferation of the dental sleep medicine market in the region. Also, the technological advancements in the healthcare sector of the region are poised to exhibit tremendous potential for growth in the years to come. The availability of convenient reimbursement policies, in conjunction with rising expenditures in these medicines, is anticipated to have a favorable effect on the future trajectory of the regional dental sleep medicine market. The U.S. is poised to hold the most substantial share of the regional market and retain it through the review period.
Europe was the second leading regional segment of the global dental sleep medicine market in 2016. It is projected to secure its spot at the second position over the next few years. Increasing investments in research & development are projected to support the expansion of the market in the region over the next couple of years.
Asia Pacific is poised to witness a rise in the patient population owing to the changing lifestyle. This, in turn, is prognosticated to drive the expansion of the dental sleep medicine market over the next couple of years. The dental sleep device market in Middle East & Africa is also anticipated to exhibit considerable growth over the next couple of years.